Jump to content

Somatomedin

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by IgG2 (talk | contribs) at 04:31, 20 July 2018 (Spelling/grammar correction). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Somatomedin C, Human.

Somatomedins are a group of proteins produced predominantly by the liver when growth hormones act on target tissue. Somatomedins inhibit the release of growth hormones by acting directly on anterior pituitary and by stimulating the secretion of somatostatin from the hypothalamus.

Somatomedins are a group of proteins that promote cell growth and division in response to stimulation by growth hormone (GH), also known as somatotropin (STH).[1]

Somatomedins have similar biological effects to somatotropin.

In addition to their actions that stimulate growth, somatomedins also stimulate production of somatostatin, which suppresses growth hormone release. Thus, levels of somatomedins are controlled via negative feedback through the intermediates of somatostatin and growth hormone. Somatomedins are produced in many tissues and have autocrine and paracrine actions in addition to their endocrine action. The liver is thought to be the predominant source of circulating somatomedins.[2]

Three forms include:

References

  1. ^ Somatomedin at eMedicine Dictionary
  2. ^ Berner Levy Physiology 6th edition|page=723|
  3. ^ Zhou A (2007). "Functional structure of the somatomedin B domain of vitronectin". Protein Science. 16 (7): 1502–8. doi:10.1110/ps.072819107. PMC 2206693. PMID 17567740.

Template:Peptidergics